Related references
Note: Only part of the references are listed.Changing nomenclature for PBC: From cirrhosis' to cholangitis'
Ulrich Beuers et al.
HEPATOLOGY (2015)
Pattern of tumor progression in liver cancer: The missing partner in trial design
Maria Reig et al.
HEPATOLOGY (2015)
Peroxisome Proliferator-Activated Receptor α Activates Human Multidrug Resistance Transporter 3/ATP-Binding Cassette Protein Subfamily B4 Transcription and Increases Rat Biliary Phosphatidylcholine Secretion
Nisanne S. Ghonem et al.
HEPATOLOGY (2014)
Pruritus in Cholestasis: Facts and Fiction
Ulrich Beuers et al.
HEPATOLOGY (2014)
Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid
Sabela Lens et al.
LIVER INTERNATIONAL (2014)
Rosiglitazone inhibits chlorpyrifos-induced apoptosis via modulation of the oxidative stress and inflammatory response in SH-SY5Y cells
Jeong Eun Lee et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Anticholestatic Effects of Bezafibrate in Patients with Primary Biliary Cirrhosis Treated with Ursodeoxycholic Acid
Akira Honda et al.
HEPATOLOGY (2013)
Estrogen sulfotransferase (SULT1E1) regulates inflammatory response and lipid metabolism of human endothelial cells via PPARγ
Yali Xu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Assessment of Pruritus Intensity: Prospective Study on Validity and Reliability of the Visual Analogue Scale, Numerical Rating Scale and Verbal Rating Scale in 471 Patients with Chronic Pruritus
Ngoc Quan Phan et al.
ACTA DERMATO-VENEREOLOGICA (2012)
Assessment of pruritus - current standards and implications for clinical practice. Consensus paper of the Action Group Pruritus Parameter of the International Working Group on Pruritus Research (AGP)
S. Staender et al.
HAUTARZT (2012)
Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions
Andreas E. Kremer et al.
HEPATOLOGY (2012)
The Itch of Liver Disease
Nora V. Bergasa
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2011)
Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988-2008
Edith M. M. Kuiper et al.
BMC GASTROENTEROLOGY (2010)
The 5-D itch scale: a new measure of pruritus
S. Elman et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Lysophosphatidic Acid Is a Potential Mediator of Cholestatic Pruritus
Andreas E. Kremer et al.
GASTROENTEROLOGY (2010)
The Potent Bile Acid Sequestrant Colesevelam Is Not Effective in Cholestatic Pruritus: Results of a Double-Blind, Randomized, Placebo-Controlled Trial
Edith M. M. Kuiper et al.
HEPATOLOGY (2010)
Ursodeoxycholic acid in primary biliary cirrhosis: Reply
Ulrich Beuers et al.
JOURNAL OF HEPATOLOGY (2009)
The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study
Shinji Iwasaki et al.
HEPATOLOGY RESEARCH (2008)
Fibrate for treatment of primary biliary cirrhosis
Shinji Iwasaki et al.
HEPATOLOGY RESEARCH (2007)
The efficacy and safety of bile acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus
Puneeta Tandon et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Sertraline as a first-line treatment for cholestatic pruritus
Marlyn J. Mayo et al.
HEPATOLOGY (2007)
Long-term effect of bezafibrate on parameters of hepatic fibrosis in primary biliary cirrhosis
Kenji Ohmoto et al.
JOURNAL OF GASTROENTEROLOGY (2006)
Bezafibrate may attenuate biliary damage associated with chronic liver diseases accompanied by high serum biliary enzyme levels
Ryuichi Kita et al.
JOURNAL OF GASTROENTEROLOGY (2006)
Long-term fibrate treatment for PBC
M Nakamuta et al.
JOURNAL OF GASTROENTEROLOGY (2005)
Prospective randomized crossover trial of combination therapy with bezafibrate and UDCA for primary biliary cirrhosis
J Itakura et al.
HEPATOLOGY RESEARCH (2004)
Multidrug resistance3 is in situ detected in the liver of patients with primary biliary cirrhosis, and induced in human hepatoma cells by bezafibrate
T Matsumoto et al.
HEPATOLOGY RESEARCH (2004)
The Liver Disease Symptom Index 2.0; Validation of a disease-specific questionnaire
SM van der Plas et al.
QUALITY OF LIFE RESEARCH (2004)
Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARα-mediated redistribution of ABCB4
J Shoda et al.
JOURNAL OF LIPID RESEARCH (2004)
Peroxisome proliferator-activated receptor α (PPARα)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice
T Kok et al.
BIOCHEMICAL JOURNAL (2003)
Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study
R Terg et al.
JOURNAL OF HEPATOLOGY (2002)
Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis
MI Prince et al.
GUT (2002)
Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators
P Delerive et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Peroxisome proliferator-activated receptors and hepatic stellate cell activation
T Miyahara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
